Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added links to related topics Melanoma and MedlinePlus Genetics in the study page's related topics section.
    Difference
    0.2%
    Check dated 2026-03-14T12:39:45.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Melanoma is removed from the related topics section. The site revision is updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-07T13:17:52.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added related topic links for Melanoma and MedlinePlus Genetics on the Study Details page.
    Difference
    0.2%
    Check dated 2026-02-21T03:51:04.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and removed Revision: v3.4.1 along with the topics Melanoma and related topics: MedlinePlus Genetics; these are metadata updates and do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T17:39:41.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page adds a melanoma topic tag, related topics: MedlinePlus Genetics, and revision v3.4.1 (replacing v3.4.0); these metadata updates do not alter the study content, eligibility criteria, or reported outcomes, and to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-06T11:33:40.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Summary
    The page adds a Melanoma label and MedlinePlus Genetics related topics, and updates the revision badge to v3.4.1 (removing v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-05T12:23:09.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.